MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dudley, D. T.
Right arrow Articles by Weishaar, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dudley, D. T.
Right arrow Articles by Weishaar, R. E.

Subclasses of angiotensin II binding sites and their functional significance

DT Dudley, RL Panek, TC Major, GH Lu, RF Bruns, BA Klinkefus, JC Hodges and RE Weishaar

Department of Signal Transduction, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105.

Specific binding sites for angiotensin II were identified in the rabbit adrenal gland and uterus and in the rat liver and were divided into two subclasses based on inhibition by nonpeptide ligands. Peptide ligands affected binding equally in all three tissues. However, the nonpeptide antagonists Dup 753 and Exp 6803 blocked angiotensin II binding to adrenal and liver homogenates at nanomolar concentrations but exerted only a minimal effect on binding to uterine homogenates. The nonpeptide PD 123319 potently blocked angiotensin II binding to uterine homogenates but had no effect on adrenal or liver homogenates at concentrations up to 10 microM. Further analysis of angiotensin II binding in uterus showed that both sites are present, with the PD 123319-sensitive site predominating. Additionally, the nonhydrolyzable GTP analogue 5'-guanylyl-imidodiphosphate was able to modulate binding to liver and to the Dup 753-sensitive site in uterus but not that to the PD 123319-sensitive site. Saralasin and the nonpeptide antagonists Dup 753 and Exp 6803 blocked angiotensin II-stimulated accumulation of inositol phosphates in cultured Clone 9 cells and also relaxed aortic rings previously contracted with angiotensin II. In contrast, PD 123319 had no effect on either angiotensin II-stimulated inositol phosphate accumulation or vasoconstriction. Saralasin and Exp 6803, but not PD 123319, lowered blood pressure in renal hypertensive rats following intravenous administration. These results suggest the existence of two subclasses of angiotensin II binding sites, which differ in their tissue distribution and affinity for the nonpeptide ligands Dup 763, Exp 6803, and PD 123319. Although no functional role for the PD 123319- sensitive subclass has yet been identified, the Dup 753/Exp 6803- sensitive subclass plays an important role in mediating inositol phosphate metabolism, vascular contractile activity, and blood pressure regulation.

Volume 38, Issue 3, pp. 370-377, 09/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Exp PhysiolHome page
M. L Chappellaz and F. G Smith
Dose-dependent systemic and renal haemodynamic effects of angiotensin II in conscious lambs: role of angiotensin AT1 and AT2 receptors
Exp Physiol, November 1, 2005; 90(6): 837 - 845.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Enyeart, S. J. Danthi, H. Liu, and J. A. Enyeart
Angiotensin II Inhibits bTREK-1 K+ Channels in Adrenocortical Cells by Separate Ca2+- and ATP Hydrolysis-dependent Mechanisms
J. Biol. Chem., September 2, 2005; 280(35): 30814 - 30828.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Guimaraes and H. Pinheiro
Functional evidence that in the cardiovascular system AT1 angiotensin II receptors are AT1B prejunctionally and AT1A postjunctionally
Cardiovasc Res, August 1, 2005; 67(2): 208 - 215.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D.-P. Li and H.-L. Pan
Angiotensin II Attenuates Synaptic GABA Release and Excites Paraventricular-Rostral Ventrolateral Medulla Output Neurons
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1035 - 1045.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. M. Siragy, C. Xue, P. Abadir, and R. M. Carey
Angiotensin Subtype-2 Receptors Inhibit Renin Biosynthesis and Angiotensin II Formation
Hypertension, January 1, 2005; 45(1): 133 - 137.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Nithipatikom, B. B. Holmes, M. J. McCoy, C. J. Hillard, and W. B. Campbell
Chronic administration of nitric oxide reduces angiotensin II receptor type 1 expression and aldosterone synthesis in zona glomerulosa cells
Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E820 - E827.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. Nap, J. C Balt, M. Pfaffendorf, and P. A van Zwieten
No involvement of the AT2-receptor in angiotensin II-enhanced sympathetic transmission in vitro
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2003; 4(2): 100 - 105.
[Abstract] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
J. C Balt, M.-J. Mathy, A. Nap, M. Pfaffendorf, and P. A van Zwieten
Involvement of the AT2-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2002; 3(3): 181 - 187.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
Q. Wang, M. Liu, B. Mullah, D. P. Siderovski, and R. R. Neubig
Receptor-selective Effects of Endogenous RGS3 and RGS5 to Regulate Mitogen-activated Protein Kinase Activation in Rat Vascular Smooth Muscle Cells
J. Biol. Chem., July 5, 2002; 277(28): 24949 - 24958.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Xu, D. Kumar, J. R. B. Dyck, W. R. Ford, A. S. Clanachan, G. D. Lopaschuk, and B. I. Jugdutt
AT1 and AT2 receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts
Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1206 - H1215.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
S. Phoon and L. G. Howes
Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT2- receptors
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2002; 3(1): 36 - 39.
[Abstract] [PDF]


Home page
J. Histochem. Cytochem.Home page
K. Hirasawa, Y. Sato, Y. Hosoda, T. Yamamoto, and H. Hanai
Immunohistochemical Localization of Angiotensin II Receptor and Local Renin-Angiotensin System in Human Colonic Mucosa
J. Histochem. Cytochem., February 1, 2002; 50(2): 275 - 282.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K.H. Schauser, A.H. Nielsen, H. Winther, V. Dantzer, and K. Poulsen
Localization of the Renin-Angiotensin System in the Bovine Ovary: Cyclic Variation of the Angiotensin II Receptor Expression
Biol Reprod, December 1, 2001; 65(6): 1672 - 1680.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. R. Rosenfeld
Mechanisms regulating angiotensin II responsiveness by the uteroplacental circulation
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1025 - R1040.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
T. J Bivalacqua, H. C Champion, A. L Hyman, D. B McNamara, and P. J Kadowitz
Analysis of responses to angiotensin II in the mouse
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S48 - S53.
[Abstract] [PDF]


Home page
Exp. Biol. Med.Home page
A. V. Ferguson, D. L.S. Washburn, and K. J. Latchford
Hormonal and Neurotransmitter Roles for Angiotensin in the Regulation of Central Autonomic Function
Experimental Biology and Medicine, February 1, 2001; 226(2): 85 - 96.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. Xu and J. J. Enyeart
Properties of ATP-dependent K+ channels in adrenocortical cells
Am J Physiol Cell Physiol, January 1, 2001; 280(1): C199 - C215.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. MYOU, M. FUJIMURA, K. KURASHIMA, H. TACHIBANA, K. WATANABE, and T. HIROSE
Type 1 Angiotensin II Receptor Antagonism Reduces Antigen-induced Airway Reactions
Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 45 - 49.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. E. Cox, C. E. Williams, and C. R. Rosenfeld
Angiotensin II indirectly vasoconstricts the ovine uterine circulation
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2000; 278(2): R337 - R344.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. S. Lambers, S. G. Greenberg, and K. E. Clark
Functional role of angiotensin II type 1 and 2 receptors in regulation of uterine blood flow in nonpregnant sheep
Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H353 - H359.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
W. R. Ford, A. S. Clanachan, and B. I. Jugdutt
Characterization of Cardioprotection Mediated by AT2 Receptor Antagonism After Ischemia-Reperfusion in Isolated Working Rat Hearts
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(3): 211 - 221.
[Abstract] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. J. Bivalacqua, A. Dalal, H. C. Champion, and P. J. Kadowitz
Role of AT1 receptors and autonomic nervous system in mediating acute pressor responses to ANG II in anesthetized mice
Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E838 - E847.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. GRUDEN, S. THOMAS, D. BURT, W. ZHOU, G. CHUSNEY, L. GNUDI, and G. VIBERTI
Interaction of Angiotensin II and Mechanical Stretch on Vascular Endothelial Growth Factor Production by Human Mesangial Cells
J. Am. Soc. Nephrol., April 1, 1999; 10(4): 730 - 737.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Inoue, Z. Mi, D. G. Gillespie, R. K. Dubey, and E. K. Jackson
Angiotensin Receptor Subtype 1 Mediates Angiotensin II Enhancement of Isoproterenol-Induced Cyclic AMP Production in Preglomerular Microvascular Smooth Muscle Cells
J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1229 - 1234.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. Peters, N. ObermÜller, A. Woyth, B. Peters, C. Maser-Gluth, B. KrÄnzlin, and N. Gretz
Losartan and Angiotensin II Inhibit Aldosterone Production in Anephric Rats via Different Actions on the Intraadrenal Renin-Angiotensin System
Endocrinology, February 1, 1999; 140(2): 675 - 682.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. Usui, T. Ichiki, M. Katoh, K. Egashira, and A. Takeshita
Regulation of Angiotensin II Receptor Expression by Nitric Oxide in Rat Adrenal Gland
Hypertension, September 1, 1998; 32(3): 527 - 533.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X.-H. Jin, Z.-Q. Wang, H. M. Siragy, R. L. Guerrant, and R. M. Carey
Regulation of jejunal sodium and water absorption by angiotensin subtype receptors
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R515 - R523.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T.-C. Fang and W.-C. Huang
Angiotensin Receptor Blockade Blunts Hyperinsulinemia-Induced Hypertension in Rats
Hypertension, August 1, 1998; 32(2): 235 - 242.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K.H. Schauser, A.H. Nielsen, H. Winther, V. Dantzer, and K. Poulsen
Autoradiographic Localization and Characterization of Angiotensin II Receptors in the Bovine Placenta and Fetal Membranes
Biol Reprod, July 1, 1998; 59(3): 684 - 692.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. R. Ford, A. S. Clanachan, G. D. Lopaschuk, R. Schulz, and B. I. Jugdutt
Intrinsic ANG II type 1 receptor stimulation contributes to recovery of postischemic mechanical function
Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1524 - H1531.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. B. Thompson, S. M. Wade, J. K. Harrison, M. N. Salafranca, and R. R. Neubig
Cotransfection of Second and Third Intracellular Loop Fragments Inhibit Angiotensin AT1a Receptor Activation of Phospholipase C in HEK-293 Cells
J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 216 - 222.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. R. Kaiser, B. E. Cox, T. A. Roy, and C. R. Rosenfeld
Differential development of umbilical and systemic arteries. I. ANG II receptor subtype expression
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R797 - R807.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Wharton, K. Morgan, R. A. D. Rutherford, J. D. Catravas, A. Chester, B. F. Whitehead, M. R. D. Leval, M. H. Yacoub, and J. M. Polak
Differential Distribution of Angiotensin AT2 Receptors in the Normal and Failing Human Heart
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 323 - 336.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. C. Champion, M. A. Czapla, and P. J. Kadowitz
Responses to angiotensin peptides are mediated by AT1 receptors in the rat
Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E115 - E123.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. G. Spinale, H. H. Holzgrefe, R. Mukherjee, M. L. Webb, R. B. Hird, M. J. Cavallo, J. R. Powell, and W. H. Koster
Angiotensin-Converting Enzyme Inhibition and Angiotensin II Subtype-1 Receptor Blockade during the Progression of Left Ventricular Dysfunction: Differential Effects on Myocyte Contractile Processes
J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1082 - 1094.
[Abstract] [Full Text]


Home page
CirculationHome page
K. Tsuchiya, M. Horie, M. Watanuki, C. A. Albrecht, K. Obayashi, H. Fujiwara, and S. Sasayama
Functional Compartmentalization of ATP Is Involved in Angiotensin II–Mediated Closure of Cardiac ATP-Sensitive K+ Channels
Circulation, November 4, 1997; 96(9): 3129 - 3135.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Benetos, B. I. Levy, P. Lacolley, F. Taillard, M. Duriez, and M. E. Safar
Role of Angiotensin II and Bradykinin on Aortic Collagen Following Converting Enzyme Inhibition in Spontaneously Hypertensive Rats
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3196 - 3201.
[Abstract] [Full Text]


Home page
HypertensionHome page
H. C. Champion and P. J. Kadowitz
Analysis of the Effects of Candesartan in the Mesenteric Vascular Bed of the Cat
Hypertension, November 1, 1997; 30(5): 1260 - 1266.
[Abstract] [Full Text]


Home page
HypertensionHome page
C. B. Gonzalez, V. L. M. Herrera, and N. Ruiz-Opazo
Renal Immunocytochemical Distribution and Pharmacological Properties of the Dual Angiotensin II/AVP Receptor
Hypertension, April 1, 1997; 29(4): 957 - 961.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Opocher, S. Rocco, M. Cimolato, B. Vianello, G. Arnaldi, and F. Mantero
Angiotensin II Receptors in Cortical and Medullary Adrenal Tumors
J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 865 - 869.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Obayashi, M. Horie, L.-H. Xie, K. Tsuchiya, A. Kubota, H. Ishida, and S. Sasayama
Angiotensin II Inhibits Protein Kinase A–Dependent Chloride Conductance in Heart via Pertussis Toxin–Sensitive G Proteins
Circulation, January 7, 1997; 95(1): 197 - 204.
[Abstract] [Full Text]


Home page
HypertensionHome page
J. Laredo, J. R. Shah, Z.-r. Lu, B. P. Hamilton, and J. M. Hamlyn
Angiotensin II Stimulates Secretion of Endogenous Ouabain From Bovine Adrenocortical Cells via Angiotensin Type 2 Receptors
Hypertension, January 1, 1997; 29(1): 401 - 407.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. L. Dieguez-Lucena, P. Aranda-Lara, M. Ruiz-Galdon, J. Garcia-Villanova, M. Morell-Ocana, and A. Reyes-Engel
Angiotensin I–Converting Enzyme Genotypes and Angiotensin II Receptors: Response to Therapy
Hypertension, July 1, 1996; 28(1): 98 - 103.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Zhang and R. E. Pratt
The AT2 Receptor Selectively Associates with Gialpha 2 and Gialpha 3 in the Rat Fetus
J. Biol. Chem., June 21, 1996; 271(25): 15026 - 15033.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
U. Ikeda, Y. Maeda, Y. Kawahara, M. Yokoyama, and K. Shimada
Angiotensin II Augments Cytokine-Stimulated Nitric Oxide Synthesis in Rat Cardiac Myocytes
Circulation, November 1, 1995; 92(9): 2683 - 2689.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
B. Mlinar, B. A. Biagi, and J. J. Enyeart
Losartan-sensitive AII Receptors Linked to Depolarization- dependent Cortisol Secretion through a Novel Signaling Pathway
J. Biol. Chem., September 8, 1995; 270(36): 20942 - 20951.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. de Leon, M.-C. Bonhomme, G. Thibault, and R. Garcia
Localization of Atrial Natriuretic Factor Receptors in the Mesenteric Arterial Bed : Comparison With Angiotensin II and Endothelin Receptors
Circ. Res., July 1, 1995; 77(1): 64 - 72.
[Abstract] [Full Text]


Home page
HypertensionHome page
B. Williams, A. Q. Baker, B. Gallacher, and D. Lodwick
Angiotensin II Increases Vascular Permeability Factor Gene Expression by Human Vascular Smooth Muscle Cells
Hypertension, May 1, 1995; 25(5): 913 - 917.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics